BlackRock, Inc. 13D and 13G filings for Boston Scientific Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-25 1:48 pm Sale | 2023-12-31 | 13G | Boston Scientific Corporation BSX | BlackRock Inc. BLK | 127,036,665 8.700% | -10,765,981 (-7.81%) | Filing |
| 2023-02-14 11:31 am Sale | 2022-12-31 | 13G | Boston Scientific Corporation BSX | BlackRock Inc. BLK | 137,802,646 9.600% | -2,313,619 (-1.65%) | Filing |
| 2023-01-24 1:56 pm Purchase | 2022-12-31 | 13G | Boston Scientific Corporation BSX | BlackRock Inc. BLK | 140,116,265 9.800% | 12,198,610 (+9.54%) | Filing |
| 2022-02-08 5:12 pm Sale | 2021-12-31 | 13G | Boston Scientific Corporation BSX | BlackRock Inc. BLK | 127,917,655 9.000% | -8,044,462 (-5.92%) | Filing |
| 2021-02-05 08:03 am Purchase | 2020-12-31 | 13G | Boston Scientific Corporation BSX | BlackRock Inc. BLK | 135,962,117 9.500% | 34,358,286 (+33.82%) | Filing |